Sugi Predict

Sugi Predict / Compounds / SCHEMBL1922326

SCHEMBL1922326

SCHEMBL1922326

CCc1nn2c(-c3ccc(Cl)cc3Cl)c(C)oc2c1C(=O)N1CCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ DPP4 P27487 3/20 0.44
▸ DPP8 Q6V1X1 3/20 0.44
▸ DPP9 Q86TI2 2/20 0.44
▸ CNR1 P21554 5/20 0.42
▸ ALPL P05186 4/20 0.42
▸ CNR2 P34972 3/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ GFER P55789 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1922608 0.99 NPC1 (0.46) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL1922932 0.93 SMN1; SMN2 (0.48) NPC1RAB9AMEN1KMT2ADPP4
SCHEMBL1923011 0.87 RAB9A (0.49) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL1922183 0.86 MARS1 (0.40) NPC1RAB9AKMT2ADPP4DPP8
SCHEMBL1922346 0.83 MAPT (0.46) NPC1RAB9AKMT2ADPP4DPP8
SCHEMBL1922248 0.79 GPBAR1 (0.45) DPP4DPP8DPP9TSHRSMN1; SMN2
SCHEMBL2255531 0.78 LMNA (0.34) KMT2ADPP4DPP8DPP9CNR1
SCHEMBL1922628 0.77 DPP4 (0.42) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL2255880 0.77 CRHR1 (0.40) KMT2ADPP4DPP8
SCHEMBL2260849 0.77 DPP4 (0.41) DPP4DPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994203-B2 Organic compounds NOVARTIS AG (CH) 2011-08-09 — — US claimed
US-20100035874-A1 Organic compounds NOVARTIS AG (CH) 2010-02-11 — — US claimed
US-7994203-B2 Organic compounds NOVARTIS AG (CH) 2011-08-09 — — US disclosed
US-7994203-B2 Organic compounds NOVARTIS AG (CH) 2011-08-09 — — US disclosed
US-7994203-B2 Organic compounds NOVARTIS AG (CH) 2011-08-09 — — US disclosed
EP-2328902-A1 PYRAZOLO [5,1-B]OXAZOLE DERIVATIVES AS CRF1 ANTAGONISTS Novartis AG (CH) 2011-06-08 — — EP disclosed
WO-2010015628-A1 PYRAZOLO [5,1-B] OXAZOLE DERIVATIVES AS CRF1 ANTAGONISTS NOVARTIS AG (CH) 2010-02-11 — — WO disclosed
WO-2010015628-A1 PYRAZOLO [5,1-B] OXAZOLE DERIVATIVES AS CRF1 ANTAGONISTS NOVARTIS AG (CH) 2010-02-11 — — WO disclosed
US-20100035874-A1 Organic compounds NOVARTIS AG (CH) 2010-02-11 — — US disclosed
US-20100035874-A1 Organic compounds NOVARTIS AG (CH) 2010-02-11 — — US disclosed
US-20100035874-A1 Organic compounds NOVARTIS AG (CH) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035874-A1 Organic compounds CRH, CRHR1, CRHR2 NPC1 1952/4885RAB9A 3388/4885MEN1 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.